- Home
- GXAI vs HKPD Comparison
GXAI vs HKPD Comparison
Compare GXAI & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GXAI | HKPD |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 10.6M |
| IPO Year | 2023 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GXAI | HKPD |
|---|---|---|
| Price | $1.12 | $0.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 168.6K | 27.7K |
| Earning Date | 11-13-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $694,278.00 | ★ $20,313,818.00 |
| Revenue This Year | $42,959.35 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23205.74 | 21.72 |
| 52 Week Low | $1.00 | $0.68 |
| 52 Week High | $2.96 | $3.09 |
Technical Indicators
Market Signals| Indicator | GXAI | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 50.77 |
| Support Level | $1.07 | $0.76 |
| Resistance Level | $1.19 | $0.84 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 13.64 | 55.56 |
Price Performance
Historical ComparisonAbout GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.